Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
Open Access
- 9 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-10
- https://doi.org/10.1038/s41598-021-91652-y
Abstract
The copy number (CN) gain of protooncogenes is a frequent finding in gastric carcinoma (GC), but its prognostic implication remains elusive. The study aimed to characterize the clinicopathological features, including prognosis, of GCs with copy number gains in multiple protooncogenes. Three hundred thirty-three patients with advanced GC were analyzed for their gene ratios in EGFR, GATA6, IGF2, and SETDB1 using droplet dPCR (ddPCR) for an accurate assessment of CN changes in target genes. The number of GC patients with 3 or more genes with CN gain was 16 (4.8%). Compared with the GCs with 2 or less genes with CN gain, the GCs with 3 or more CN gains displayed more frequent venous invasion, a lower density of tumor-infiltrating lymphocytes, and lower methylation levels of L1 or SAT-alpha. Microsatellite instability-high tumors or Epstein–Barr virus-positive tumors were not found in the GCs with 3 or more genes with CN gain. Patients of this groups also showed the worst clinical outcomes for both overall survival and recurrence-free survival, which was persistent in the multivariate survival analyses. Our findings suggest that the ddPCR-based detection of multiple CN gain of protooncogenes might help to identify a subset of patients with poor prognosis.Funding Information
- Ministry of Education, Science and Technology (2019R1F1A106122)
- Korea Health Industry Development Institute (HI14C1277)
This publication has 24 references indexed in Scilit:
- Clinicopathological and Survival Analysis of Japanese Patients with Resected Non-Small-Cell Lung Cancer Harboring NKX2-1, SETDB1, MET, HER2, SOX2, FGFR1, or PIK3CA Gene AmplificationJournal of Thoracic Oncology, 2015
- Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast CancerPathobiology, 2015
- Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implicationGastric Cancer, 2015
- SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathwayThe Journal of Pathology, 2014
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasionAsian Journal of Andrology, 2014
- Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesisOncogene, 2013
- Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variationNucleic Acids Research, 2012
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetNature, 2011
- Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?Cell Cycle, 2006